Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.5000 (-2.6%) ($7.1600 - $7.7600) on Thu. Apr. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.36% (three month average) | RSI | 35 | Latest Price | $7.5000(-2.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(10%) XLB(10%) LIT(9%) IPO(8%) FXI(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.68% in a week (0% probabilities). SHY(-13%) XLU(-5%) XBI(-5%) IBB(-5%) XLP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.68% (StdDev 5.36%) | Hourly BBV | 0 () | Intraday Trend | -3.4% | | | |
|
1 - 5 Day Possible Target | $-1.81(-124.13%) | Resistance Level | $7.95 | 5 Day Moving Average | $7.62(-1.57%) | 10 Day Moving Average | $7.85(-4.46%) | 20 Day Moving Average | $7.95(-5.66%) | To recent high | -33.3% | To recent low | 6.1% | Market Cap | $64m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |